Aprea Therapeutics Inc. (APRE)

NASDAQ: APRE · Real-Time Price · USD

1.66

-0.09 (-5.14%)

At close: Apr 29, 2025, 3:40 PM

Aprea Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	n/a	583.23K	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	7.05K	186.44K	271.68K	229.61K	170.25K	8.32K	7.93K
Gross Profit	n/a	576.18K	-186.44K	-271.68K	-229.61K	-170.25K	-8.32K	-7.93K
Operating Income	-14.32M	-15.47M	38.18M	-38.04M	-52.15M	-31.04M	-16.49M	-15.85M
Interest Income	n/a	n/a	448.67K	1.65K	222.65K	n/a	n/a	n/a
Pretax Income	-12.96M	-14.29M	-112.66M	-37.13M	-53.48M	-28.06M	-15.53M	-15.19M
Net Income	-12.96M	-14.29M	-224.88M	-36.54M	-53.92M	-26.41M	-15.53M	-15.19M
Selling & General & Admin	6.46M	8.42M	20.97M	13.55M	14.93M	8.59M	2.29M	2.46M
Research & Development	9.36M	7.63M	16.4M	23.9M	37.88M	20.95M	14.19M	13.39M
Other Expenses	n/a	n/a	76.02M	n/a	n/a	n/a	n/a	n/a
Operating Expenses	15.82M	16.05M	37.37M	37.45M	52.81M	29.54M	16.49M	15.85M
Interest Expense	n/a	n/a	448.67K	n/a	222.65K	156.35K	182.00	15.00
Selling & Marketing Expenses	n/a	-7.05K	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	16.06M	37.37M	37.45M	52.81M	29.54M	16.49M	15.85M
Income Tax Expense	n/a	n/a	112.21M	-590.73K	437.99K	-1.65M	961.32K	-662.13K
Shares Outstanding (Basic)	5.51M	3.62M	82.85K	1.06M	1.06M	1M	703.78K	703.78K
Shares Outstanding (Diluted)	5.51M	3.62M	82.85K	1.06M	1.06M	1M	703.78K	703.78K
EPS (Basic)	-2.35	-3.95	-2.71K	-34.33	-51.02	-26.28	-22.06	-21.58
EPS (Diluted)	-2.35	-3.95	-2.71K	-34.33	-51.02	-26.28	-22.06	-21.58
EBITDA	-14.32M	-14.28M	-112.48M	-36.86M	-53.25M	-27.89M	-15.52M	-15.18M
EBIT	n/a	-14.29M	-112.66M	-37.13M	-53.48M	-28.06M	-15.53M	-15.19M
Depreciation & Amortization	n/a	7.05K	186.44K	271.68K	229.61K	170.25K	8.32K	7.93K

Advertisement

Aprea Therapeutics Inc. (APRE)

Aprea Therapeutics Income Statement